Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
GLOBETECH PUBLISHING LLC

Imaging for Amyloid Deposits Also Shows Promise for Detecting Cardiac Amyloidosis

By Medimaging International staff writers
Posted on 21 Feb 2013
Whereas amyloid imaging may now be most associated with detecting plaques in the brain, it also has the potential to alter the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research, positron emission tomography (PET) with 11C-PIB (Pittsburgh compound B) can effectively visualize amyloid deposits in the heart. Currently, there is no other noninvasive test available for specific diagnosis.

The study’s findings were published in the February 2013 issue of the Journal of Nuclear Medicine. Cardiac amyloidosis is a deadly disorder caused by abnormal amyloid deposits in the heart tissue. Early diagnosis before structural change to the heart tissue has occurred is important for disease prognosis and for treatment monitoring. Echocardiography is the current mainstay of imaging in cardiac amyloidosis; a cardiac biopsy is used to validate diagnosis.

“Imaging with 11C-PIB provides a noninvasive and specific means of showing distribution of amyloid in an organ. This gives a unique opportunity to follow and monitor therapy, as amyloid deposits in the heart should decrease with successful therapy,” said Gunnar Antoni, PhD, from department of medicinal chemistry, Uppsala University (Sweden), and lead author of the research.

The study included 10 patients diagnosed with cardiac amyloidosis and five healthy individuals. PET/computed tomography (CT) with 11C-PIB was used to visualize amyloid deposits in the heart and with 11C-acetate to measure myocardial blood flow.

Uptake of 11C-PIB was measured 15–25 minutes after injection. Obvious uptake of 11C-PIB was noted in the left ventricle wall of all patients with cardiac amyloidosis, while no uptake was seen in the healthy volunteers. In half of the patients, 11C-PIB was also detected in the right ventricle wall, and nine of the patients had signs of reversible uptake, with a maximum concentration at 10–15 minutes after injection. Myocardial blood flow was significantly lower in patients with cardiac amyloidosis; however, no significant correlation between myocardial blood flow and 11C-PIB uptake was found.

“This study emphasizes the strength of molecular imaging for detecting an underlying and significant molecular aberration in a disease that presents with unspecific symptoms and signs,” noted Dr. Antoni. “The potential for molecular imaging to provide valuable information for other diseases is of great value to the field of medicine.”

Related Links:
Uppsala University






Channels

Radiography

view channel
Image: Carestream DRX-Revolution Mobile X-ray System with Wireless DRX Detector (Photo courtesy of Carestream).

Wireless Transmission of Digital Radiography Images to PACS Enhances Portable Radiography Workflow

Researchers evaluated the workflow and performance of the DDR and CR systems by timing and evaluating transmission of chest X-ray examinations to a PACS. The study was carried out at the Hong Kong... Read more

MRI

view channel

Global Research Alliance Conducts Largest Collaborative Study of the Brain's Genetics

Scientists from the Keck School of Medicine, University of California (UC; Los Angeles, CA, USA) found eight common aging-related mutations of the human brain from over 30,000 Magnetic Resonance Imaging (MRI) scans. Approximately 300 scientists from 190 institutions are taking part in the study which aims to find targeted... Read more

Ultrasound

view channel

Guidelines Released for Quantitative Monitoring of Critically Ill and Surgery Patients Using Echocardiography

The American Society of Echocardiography (ASE; Morrisville, NC, USA) has published clinical guidelines describing how and when echocardiography can be used for medical and surgical therapy in adult patients. The guidelines were published in the January 2015 issue of the American Society of Echocardiography.... Read more

General/Advanced Imaging

view channel
Image: Dr. Miles was part of the team that helped identify facial measurements in children with autism that may lead to a screening tool for young children and provide clues to its genetic causes (Photo courtesy of Rebecca F. Miller).

Advanced 3D Facial Imaging Designed to Help in Early Identification of Autism

Autism is a range of closely related disorders observed in patients who exhibit a shared assortment of symptoms, including delays in learning to communicate and interrelate socially. Early detection of... Read more

Imaging IT

view channel

Potential Cost of Data Breaches of Protected Health Information Could Reach USD 5.6 Billion Annually

The healthcare industry and institutions face an ever-increasing threat of data breaches to clinical and patient information. Cybercriminals are attracted to Protected Health Information (PHI) such as Social Security Numbers (SSN) on Medicare cards, and other sensitive medical information stored online on an institutions'... Read more

Industry News

view channel

Trend Toward Smaller Ultrasound Devices as Sales Increase

World market revenues for the ultrasound sector in 2014 were USD 5.8 billion, while market growth rate was 5%. Factors like the absence of radiation, the smaller form factor, and the relative low cost compared to other imaging technologies have fueled the trend. Growth is expected to continue until 2018. The current... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.